Apple Praise Borders On Hyperbole

Every single  living, breathing analyst on Wall Street (and some that are deceased) has come out with a bull call on Apple ($AAPL) this morning on the heels of the company’s blockbuster first quarter earnings announcement.  In over a decade trading this market, I have never seen anything like this analyst lovefest. 

Never.

Don’t believe me?  How ’bout this?

Clyde Montevirgen, Standard & Poor’s: Buy rating; new target $295, up from $270.

Samuel Wilson, JMP Securities: Market Outperform rating; target to $290, from $260.

Peter Misek, Canaccord Adams: Buy rating; target to $325, from $300.

Robert Cihra, Caris & Co.: Buy rating; target to $310, from $300.

Tavis McCourt, Morgan Keegan: Outperform rating; target now $325.

Keith Bachman, BMO Capital: Outperform rating, target now $290, up from $265.

Doug Reid, Thomas Weisel Partners: Overweight rating; target to $320, from $300.

Andy Hargreaves, Pacific Crest: Outperform; target to $330, from $300.

Jeffrey Fidicaro, Susquehanna: Positive rating; target to $300, from $275.

Shaw Wu, Kaufman Bros.: Buy rating; target to $315, from $305.

Scott Craig, Bank of America/Merrill Lynch: Repeats Buy rating; target to $300 from $260.

Mike Abramsky, RBC Capital: Outperform rating; target to $350, from $275.

Gene Munster, Piper Jaffray: Overweight rating; target to $323, from $299.

Toni Sacconaghi, Bernstein Research: Overweight rating; target to $300, from $275.

Yair Reiner, Oppenheimer: Outperform rating; target to $320, from $285.

Mark Moskowitz, J.P. Morgan: Overweight rating; target to $316m, from $305.

Richard Gardner, Citigroup: Buy rating; target to $320, from $300.

Phil Cusick, Macquarie: Outperform rating; target to $325, from $250.

Bill Shope: Credit Suisse: Outperform rating; target to $315, from $300.

Ben Reitzes, Barclays Capital: Overweight rating; target to $315, from $300.

Katy Huberty, Morgan Stanley: Overweight rating; target to $275, from $250.

Chris Whitmore, Deutsche Bank: Buy rating; target to $350 from $325.

Told ya.

Full Disclosure: Nothing on this site should ever be considered to be advice, research or an invitation to buy or sell any securities, please see my Terms & Conditions page for a full disclaimer.